Updated July 28 at 11:29pm
Biotechnology
70 results total, viewing 11 - 20
Life sciences company CytoSolv Inc. has been acquired by Semma Therapeutics of Cambridge, Mass., according to a Slater Technology Fund press release. more
Gov. Gina M. Raimondo and Commerce Secretary Stefan Pryor launched three new incentive programs on Wednesday in an effort to grow the state’s economy. more
Rhode Island ranked 33rd in the nation for venture-capital investment in the first quarter, which featured only one deal - $5 million to IlluminOss Medical Inc. more
Ximedica, a medical-technology-development company, has acquired Accel Biotech based in Los Gatos, Calif. more
The University of Massachusetts was granted 62 utility patents in 2015, putting the school at No. 30 on a list of the Top 100 worldwide universities that were granted U.S. patents. more
Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its primary goal in a final-stage trial. more
Edward Bozzi, associate professor and coordinator of the University of Rhode Island Biotechnology Program, talked about Rhode Island BioScience Leaders, the organization that he helped found three years ago, with Providence Business News. more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, met third-quarter profit estimates as its newest products continue to take market share from rivals. more
Last week Nabsys Inc. shut its doors, costing approximately 40 people their jobs and investors about $50 million. That's the nature of the beast in the high-risk biotech field. But by some of the reaction to the company's failure, it is … more
I’m seeing lots of news reports about the end of the new Silicon Valley tech “bubble.” I put that word in quotes because the current situation doesn’t look much like the bubble of the late 1990s. But there still might soon be a broad drop in funding for startups, and a fall in the valuations of these companies. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 Next »